Cargando…
NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
Glioma is one of the most deadly types of brain cancer. As it is highly invasive, the prognosis for glioma patients remains dismal, with median survival rarely exceeding 16 months. Thus, developing a new prognostic biomarker for glioma and investigating its molecular mechanisms is necessary for the...
Autores principales: | Zheng, Guangrong, Han, Tao, Hu, Xiaomu, Yang, Zhou, Wang, Jin, Wen, Zhenyi, Li, Hengyu, Wang, Hongjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964493/ https://www.ncbi.nlm.nih.gov/pubmed/35372056 http://dx.doi.org/10.3389/fonc.2022.770628 |
Ejemplares similares
-
NCAPG as a Novel Prognostic Biomarker in Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022) -
NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
por: Ren, Wenjun, et al.
Publicado: (2022) -
LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression
por: Chen, Xi, et al.
Publicado: (2022) -
NSUN2 Promotes Tumor Progression and Regulates Immune Infiltration in Nasopharyngeal Carcinoma
por: Tong, Xinya, et al.
Publicado: (2022) -
PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022)